Financials AZITRAPAR

Equities

AZTR

US05479L1044

Market Closed - Nyse 04:00:00 2024-06-28 pm EDT 5-day change 1st Jan Change
0.0922 USD -30.15% Intraday chart for AZITRAPAR -35.25% -89.98%

Valuation

Fiscal Period: December 2023 2024 2025 2026
Capitalization 1 11.13 3.802 - -
Enterprise Value (EV) 1 11.13 3.802 3.802 3.802
P/E ratio -0.5 x -0.22 x -0.24 x -0.22 x
Yield - - - -
Capitalization / Revenue 16.2 x - - -
EV / Revenue 16.2 x - - -
EV / EBITDA - - - -
EV / FCF -1.51 x -0.41 x -0.37 x -0.29 x
FCF Yield -66.4% -246% -271% -346%
Price to Book - - - -
Nbr of stocks (in thousands) 12,098 28,805 - -
Reference price 2 0.9200 0.0922 0.0922 0.0922
Announcement Date 3/15/24 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2022 2023 2024 2025 2026
Net sales 1 - 0.686 - - -
EBITDA - - - - -
EBIT 1 - -7.616 -8.693 -9.563 -11.93
Operating Margin - -1,110.26% - - -
Earnings before Tax (EBT) - - - - -
Net income 1 -10.68 -12.64 -8.693 -9.563 -11.93
Net margin - -1,842.44% - - -
EPS 2 -90.47 -1.830 -0.4100 -0.3900 -0.4100
Free Cash Flow 1 - -7.389 -9.371 -10.31 -13.14
FCF margin - -1,077.1% - - -
FCF Conversion (EBITDA) - - - - -
FCF Conversion (Net income) - - - - -
Dividend per Share - - - - -
Announcement Date 2/21/23 3/15/24 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4
Net sales 1 - 0.09 - - - -
EBITDA - - - - - -
EBIT 1 - -2.58 - -1.892 -1.911 -1.929
Operating Margin - -2,866.71% - - - -
Earnings before Tax (EBT) - - - - - -
Net income 1 -1.943 -2.454 -2.933 -1.892 -1.911 -1.929
Net margin - -2,726.43% - - - -
EPS 2 -0.1600 0.1400 -0.1500 -0.0900 -0.0800 -0.0800
Dividend per Share - - - - - -
Announcement Date 11/14/23 3/15/24 5/9/24 - - -
1USD in Million2USD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2022 2023 2024 2025 2026
Net Debt - - - - -
Net Cash position - - - - -
Leverage (Debt/EBITDA) - - - - -
Free Cash Flow 1 - -7.39 -9.37 -10.3 -13.1
ROE (net income / shareholders' equity) - - - - -
ROA (Net income/ Total Assets) - - - - -
Assets 1 - - - - -
Book Value Per Share - - - - -
Cash Flow per Share - - - - -
Capex - 0.03 - - -
Capex / Sales - 3.87% - - -
Announcement Date 2/21/23 3/15/24 - - -
1USD in Million
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
0.0922 USD
Average target price
2 USD
Spread / Average Target
+2,069.20%
Consensus